🔗 Visit the ClinicalTrials.gov page for NCT00282100
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. | Oncotarget | 2012 | 1.55 |
| 2 | The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma. | PLoS One | 2015 | 1.46 |
| 3 | Targeted therapies in the treatment of advanced hepatocellular carcinoma. | Clin Med Insights Oncol | 2013 | 0.83 |